Skip to content
★ Sign in to follow
RF

Rennes Fondation

Related company / holding
Ebix IncXBiotech Inc.
Total declarations
35
Companies
2
▲ Purchases (23 ops.)
€16.0M
▼ Sales (10 ops.)
€19.2M

Latest filing published 13 Feb 2020 for XBiotech Inc..

Filing timeline

BuySale
Rennes Fondation

Insider track record

Disclosed buys
23
Disclosed sells
10
Signal history

Closed purchases

Market purchases
23
Positive at T+90
64%
Median T+90
+6.7%

Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 06 Jun 2019 · 2712 days ago · €8.8M
    +89.6%
    Entry US$7.80 · Close at T+365 US$14.79
  • Filed 05 Mar 2019 · 2805 days ago · €114k
    +24.2%
    Entry US$9.25 · Close at T+365 US$11.49
  • Filed 04 Mar 2019 · 2806 days ago · €38k
    +24.6%
    Entry US$9.54 · Close at T+365 US$11.89
  • Filed 14 Feb 2019 · 2824 days ago · €23k
    +72.3%
    Entry US$8.66 · Close at T+365 US$14.92

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Rennes Fondation: trading record in brief

This profile gathers the share dealings of Rennes Fondation across 2 companies, led by Ebix Inc and XBiotech Inc. We count 35 filings; the first trade dates from 25 March 2008 and the latest from 3 February 2020.

Both buying and selling appear: 23 purchases worth €16.0M, against 10 sales worth €19.2M. Taken together, the sales exceed the purchases by €3.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

In size, the median ticket on the buying side is €269k. On 3 out of 11 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 64% of cases, with a median move of +6.7%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 13 February 2020 with a transaction in XBiotech Inc. The most recent open-market purchase was published on 6 June 2019, 2,712 days ago. Typically, a trade is published a median of 5 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Rennes Fondation

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations35 total
  • ●
    Related company / holdingExecutivesXBiotech Inc.
    0SEC
    5,000,000 shares0Common StockSEC:0001209191-20-009318:0
  • ▼
    Related company / holdingExecutivesEbix Inc
    801,649 USD5SEC
    22,145 shares@ US$36.203.8% of flowcommon stockSEC:0001209191-19-047127:0
  • ▼
    Related company / holdingExecutivesEbix Inc
    2M USD6SEC
    52,855 shares@ US$38.049.3% of flowcommon stockSEC:0001209191-19-047076:0
  • ▼
    Related company / holdingExecutivesEbix Inc
    4M USD7SEC
    100,000 shares@ US$35.6116.6% of flowcommon stockSEC:0001209191-19-047076:1
  • ▼
    Related company / holdingExecutivesEbix Inc
    2M USD6SEC
    65,000 shares@ US$34.4110.5% of flowcommon stockSEC:0001209191-19-047076:2
  • ▼
    Related company / holdingExecutivesEbix Inc
    1M USD5SEC
    30,000 shares@ US$35.144.9% of flowcommon stockSEC:0001209191-19-047076:3
  • ▼
    Related company / holdingExecutivesEbix Inc
    1M USD5SEC
    30,000 shares@ US$35.244.9% of flowcommon stockSEC:0001209191-19-047076:4
  • ▼
    Related company / holdingExecutivesEbix Inc
    668,779 USD5SEC
    22,145 shares@ US$30.203.1% of flowcommon stockSEC:0001209191-19-047076:5
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    10M USD19SEC
    1,200,000 shares@ US$8.2586.7% of flowCommon StockSEC:0001209191-19-034978:0
    Canonical exit: 2 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    129,930 USD11SEC
    16,426 shares@ US$7.911.1% of flowCommon StockSEC:0001209191-19-016489:0
    Canonical exit: 2 Jun 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    42,869 USD11SEC
    5,273 shares@ US$8.130.4% of flowCommon StockSEC:0001209191-19-015316:0
    Canonical exit: 28 May 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    43,423 USD11SEC
    5,302 shares@ US$8.190.4% of flowCommon StockSEC:0001209191-19-015316:1
    Canonical exit: 29 May 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    284,542 USD11SEC
    34,999 shares@ US$8.132.5% of flowCommon StockSEC:0001209191-19-015316:2
    Canonical exit: 30 May 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    26,208 USD17SEC
    4,200 shares@ US$6.240.2% of flowCommon StockSEC:0001209191-19-010053:0
    Canonical exit: 21 Mar 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    10,956 USD19SEC
    2,200 shares@ US$4.980.1% of flowCommon StockSEC:0001209191-19-010053:1
    Canonical exit: 27 Mar 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    4,635 USD21SEC
    900 shares@ US$5.150.0% of flowCommon StockSEC:0001209191-19-010053:2
    Canonical exit: 2 Apr 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    312,550 USD11SEC
    35,000 shares@ US$8.932.7% of flowCommon StockSEC:0001209191-19-010053:3
    Canonical exit: 7 May 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    284,700 USD11SEC
    30,000 shares@ US$9.492.5% of flowCommon StockSEC:0001209191-19-010053:4
    Canonical exit: 7 May 2019 (T+90)
  • ▲
    Related company / holdingExecutivesXBiotech Inc.
    400,000 USD11SEC
    40,000 shares@ US$10.003.5% of flowCommon StockSEC:0001209191-19-010053:5
    Canonical exit: 8 May 2019 (T+90)
  • ▼
    Related company / holdingExecutivesEbix Inc
    460,000 USD17SEC
    10,000 shares@ US$46.002.1% of flowcommon stockSEC:0001209191-18-062582:0
  • ▼
    Related company / holdingExecutivesEbix Inc
    9M USD21SEC
    200,000 shares@ US$44.0040.3% of flowcommon stockSEC:0001209191-18-062582:1
  • ▼
    Related company / holdingExecutivesEbix Inc
    988,160 USD5SEC
    12,800 shares@ US$77.204.5% of flowCommon StockSEC:0001209191-18-054190:0
  • ●
    Related company / holdingExecutivesEbix Inc
    18M USD10SEC
    307,692 shares@ US$58.5046.9% of flowcommon stockSEC:0001209191-17-019171:0
  • ▲
    Related company / holdingExecutivesEbix Inc
    537,840 USD0SEC
    14,400 shares@ US$37.35Common StockSEC:0001209191-15-046442:0
    Canonical exit: 20 Aug 2015 (T+90)
  • ▲
    Related company / holdingExecutivesEbix Inc
    613,038 USD0SEC
    16,600 shares@ US$36.93Common StockSEC:0001209191-15-045800:0
    Canonical exit: 19 Aug 2015 (T+90)

25 of 35 declarations